263 related articles for article (PubMed ID: 17475004)
1. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
3. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
Marra CM; Zhao Y; Clifford DB; Letendre S; Evans S; Henry K; Ellis RJ; Rodriguez B; Coombs RW; Schifitto G; McArthur JC; Robertson K;
AIDS; 2009 Jul; 23(11):1359-66. PubMed ID: 19424052
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
5. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
[TBL] [Abstract][Full Text] [Related]
6. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL;
Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949
[TBL] [Abstract][Full Text] [Related]
7. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
Monteiro de Almeida S; Letendre S; Zimmerman J; Kolakowski S; Lazzaretto D; McCutchan JA; Ellis R
J Neuroimmunol; 2006 Oct; 179(1-2):180-5. PubMed ID: 16901548
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
11. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
Letendre S; Marquie-Beck J; Capparelli E; Best B; Clifford D; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Morgello S; Simpson D; Grant I; Ellis RJ;
Arch Neurol; 2008 Jan; 65(1):65-70. PubMed ID: 18195140
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
[TBL] [Abstract][Full Text] [Related]
13. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.
Smurzynski M; Wu K; Letendre S; Robertson K; Bosch RJ; Clifford DB; Evans S; Collier AC; Taylor M; Ellis R
AIDS; 2011 Jan; 25(3):357-65. PubMed ID: 21124201
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.
Antinori A; Perno CF; Giancola ML; Forbici F; Ippolito G; Hoetelmans RM; Piscitelli SC
Clin Infect Dis; 2005 Dec; 41(12):1787-93. PubMed ID: 16288405
[TBL] [Abstract][Full Text] [Related]
17. High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.
Firlag-Burkacka E; Swiecki P; Cielniak I; Siwak E; Gizinska J; Bakowska E; Kubicka J; Pulik P; Kowalski J; Podlasin R; Horban A
HIV Med; 2016 May; 17(5):323-6. PubMed ID: 27089861
[TBL] [Abstract][Full Text] [Related]
18. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.
Smith DM; Zárate S; Shao H; Pillai SK; Letendre SL; Wong JK; Richman DD; Frost SD; Ellis RJ;
Virology; 2009 Mar; 385(1):204-8. PubMed ID: 19100592
[TBL] [Abstract][Full Text] [Related]
19. The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
Hammond ER; Crum RM; Treisman GJ; Mehta SH; Marra CM; Clifford DB; Morgello S; Simpson DM; Gelman BB; Ellis RJ; Grant I; Letendre SL; McArthur JC;
Am J Epidemiol; 2014 Aug; 180(3):297-307. PubMed ID: 24966216
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic cerebrospinal fluid escape.
Mastrangelo A; Turrini F; de Zan V; Caccia R; Gerevini S; Cinque P
AIDS; 2019 Dec; 33 Suppl 2():S159-S169. PubMed ID: 31789816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
